Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
Titel:
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
Auteur:
Morton, Gerard Chung, Hans T. McGuffin, Merrylee Helou, Joelle D’Alimonte, Laura Ravi, Ananth Cheung, Patrick Szumacher, Ewa Liu, Stanley Al-Hanaqta, Motasem Zhang, Liying Mamedov, Alexandre Loblaw, Andrew